Patients with vascular surgery, abdominal surgery, femoral venous thrombosis, tumor lysis syndrome, acute kidney injury, and hypovolemic shock can develop stress-related gastric ulcers within 24-48 hours after the onset of critical illness, especially if they have risk factors such as prolonged mechanical ventilation and coagulopathy 1, 2
Coagulopathy is one of the strongest clinical predictors for gastrointestinal bleeding in critically ill patients (OR = 4.3, p < 0.001) 3, 4
Hypovolemic shock causes gastric hypoperfusion, which directly contributes to mucosal damage 1, 2
Acute kidney injury increases the risk of gastrointestinal bleeding in critically ill patients 1, 5

Mechanism and Time of Development

Gastric hypoperfusion due to hypovolemic shock reduces blood flow to the gastric mucosa 1, 2
Reperfusion injury after initial resuscitation can cause additional oxidative damage 5
Increased acid production due to the stress response 1
Alteration of the mucosa's protective mechanisms due to critical illness 1, 2

Incidence and Mortality

The incidence of clinically significant gastrointestinal bleeding in critically ill patients is approximately 2.6% (95% CI: 1.6%-3.6%) 1, 2
Patients with respiratory failure and coagulopathy have a 3.7% risk of developing clinically significant gastrointestinal bleeding 3
Mortality is significantly higher in critically ill patients who develop bleeding from stress ulcers (48.5%) compared to those who do not bleed (9.1%, p < 0.001) 3, 4

Recommendations for Prophylaxis

Prophylaxis for stress-related gastric ulcers should be initiated immediately upon admission of the patient 1, 2, 5
Proton pump inhibitors (PPIs) or H2 receptor antagonists (H2RAs) can be used as equivalent therapeutic options 1, 2
Early enteral nutrition, if possible, can reduce the risk of stress-related gastric ulcers 1, 5

Special Considerations

Monitoring for signs of gastrointestinal bleeding (melena, hematemesis, drop in hemoglobin) from admission 1, 5
Duration of prophylaxis should be maintained as long as risk factors and critical illness persist 5
Discontinuation of prophylaxis when critical illness is resolved or risk factors disappear 5

Warnings and Precautions

Prophylaxis should not be delayed in patients with multiple risk factors 1, 2
The combination of prolonged mechanical ventilation (>48 hours) and coagulopathy significantly increases the risk of bleeding 3, 4

Stress Ulcer Prophylaxis for Septic Patients with MELD 35

Recommended Prophylaxis

The Surviving Sepsis Campaign suggests that either PPIs or H2RAs can be used for stress ulcer prophylaxis in septic patients, but the presence of severe liver disease (MELD 35) shifts the balance toward PPIs, with a weak recommendation and low quality evidence 6, 7
Intravenous pantoprazole (40mg daily) is the preferred agent for this high-risk patient with sepsis and severe liver disease, due to its consistent acid suppression and reduced hepatic metabolism concerns 6
PPIs are preferred over H2 receptor antagonists in patients with severe liver disease due to more consistent acid suppression and reduced hepatic metabolism concerns 8, 7

Monitoring and Duration

Consider discontinuing prophylaxis when sepsis resolves and the patient is able to tolerate enteral nutrition, as recommended by the Intensive Care Medicine and Critical Care Medicine guidelines 6, 9
Early enteral nutrition, if possible, can provide additional protection against stress ulceration, according to the Critical Care Medicine guideline 9

Prophylaxis of Stress Ulcer in Septic Shock

Indications for Prophylaxis

The Surviving Sepsis Campaign guidelines recommend prophylaxis of stress ulcer in patients with sepsis or septic shock who present risk factors for gastrointestinal bleeding, and suggest using either proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) (weak recommendation, low-quality evidence) 10, 11
Prophylaxis of stress ulcer should be administered to patients with sepsis or septic shock who present risk factors for gastrointestinal bleeding 12, 10

Options for Medications

According to the Surviving Sepsis Campaign 2016 guidelines, both PPIs and H2RAs are suggested when stress ulcer prophylaxis is indicated (weak recommendation, low-quality evidence) 10, 11
The 2012 guidelines suggested preferring PPIs over H2RAs (grade 2C) 13, 14

Recommendations

The American College of Critical Care Medicine recommends not using stress ulcer prophylaxis in patients without risk factors for gastrointestinal bleeding 10, 11

GI Prophylaxis During Hospital Admissions

Risk Assessment for GI Prophylaxis

The American College of Critical Care Medicine recommends stress ulcer prophylaxis for hospitalized patients with risk factors for gastrointestinal bleeding, including mechanical ventilation, history of gastrointestinal bleeding, sepsis or septic shock, and multiple organ failure 15
Patients requiring mechanical ventilation, especially for more than 48 hours, are at increased risk for gastrointestinal bleeding 16

Recommended Prophylaxis Regimen

The American College of Critical Care Medicine recommends using either proton pump inhibitors (PPIs) or histamine-2 receptor antagonists (H2RAs) for stress ulcer prophylaxis, with a preference for PPIs in high-risk patients 15
For high-risk patients with active bleeding, a loading dose of PPI followed by continuous infusion for the first 72 hours is recommended 17
For patients after successful endoscopic therapy, twice-daily oral PPIs for 14 days, followed by once-daily dosing, is recommended 17

Evidence Supporting Recommendations

The Surviving Sepsis Campaign guidelines recommend stress ulcer prophylaxis for patients with sepsis or septic shock who have risk factors for GI bleeding, with a strong recommendation and low-quality evidence 15
PPIs are generally preferred over H2RAs due to reduced risk of rebleeding in high-risk patients 17
Hospital-acquired pneumonia may be associated with PPI use 15

Stress Ulcer Prophylaxis in Critically Ill Patients

Risk Stratification and Indications

High‑risk patients (mechanical ventilation ≥48 h, sepsis or septic shock) should receive stress‑ulcer prophylaxis; evidence graded A. The presence of either risk factor alone justifies prophylaxis, and the combination markedly increases bleeding risk【18】【19】【20】.
Patients without any recognized risk factors have a very low bleeding incidence (≈0.2 %) and do not require prophylaxis; routine use in this group is discouraged because of cost and potential adverse effects【20】.

Pharmacologic Prophylaxis Regimen

Proton‑pump inhibitors are the preferred first‑line agents for the highest‑risk patients; they achieve more reliable acid suppression and are favored when rapid, consistent gastric pH control is needed【20】.
When PPIs are unavailable, H₂‑receptor antagonists (e.g., ranitidine or cimetidine) are acceptable alternatives; studies show comparable efficacy to PPIs in preventing stress‑related bleeding【18】【19】【20】.
Cimetidine and antacids each reduce the incidence of stress‑ulcer bleeding compared with no prophylaxis (≈33 % reduction with cimetidine and ≈43 % with antacids)【18】【21】.

Adjunctive Measures

Early enteral nutrition, when tolerated, adds protective benefit against stress‑related ulceration; it should be initiated as soon as feasible in the ICU【19】【22】.
Distal (post‑pyloric) enteral feeding is more effective than gastric feeding for ulcer protection【19】【22】.
Nutritional support cannot replace pharmacologic prophylaxis but serves as an important adjunct【19】【22】.
Antacids and H₂‑antagonists were historically equally effective, but modern practice favors PPIs/H₂‑antagonists because of easier administration【21】【18】【19】.

Duration and Discontinuation

Extending prophylaxis beyond 7–10 days in patients with acute severe ulcerative colitis provides no additional benefit and increases toxicity【23】. (Applicable to prolonged courses in critical illness.)

Monitoring and Safety

Routine systemic laboratory monitoring is not required for short‑term prophylaxis, but clinicians should remain vigilant for clinical signs of gastrointestinal bleeding.

Clinical Pitfalls

Providing prophylaxis to low‑risk patients is not cost‑effective and is not recommended【18】【22】.
Risk factors for stress‑ulcer bleeding are additive; patients with multiple factors (e.g., mechanical ventilation + coagulopathy) need aggressive prophylaxis【18】【19】.